Literature DB >> 8099446

Potential role of phospholipase A2 in HL-60 cell differentiation to macrophages induced by protein kinase C activation.

Y Asaoka1, K Yoshida, Y Sasaki, Y Nishizuka.   

Abstract

2-Lysophosphatidylcholine and cis-unsaturated fatty acids such as linoleic and linolenic acids, which are the products of the hydrolysis of phosphatidylcholine catalyzed by phospholipase A2 (EC 3.1.1.4), significantly potentiate the differentiation of HL-60 cells to macrophages that is induced by either a membrane-permeant diacylglycerol or a phorbol ester. The cell differentiation was assayed by measuring the expression of CD11b, one of the cell surface markers of macrophages, and also by the appearance of phagocytic activity. Snake venom phospholipase A2 added directly to the cells is also active for this potentiation. Neither lysophosphatidylcholine, fatty acid, nor phospholipase A2 is active unless a membrane-permeant diacylglycerol or a phorbol ester is present. The results presented provide further evidence that activation of phospholipase A2 may be intimately related to the signal transduction pathway through protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099446      PMCID: PMC46624          DOI: 10.1073/pnas.90.11.4917

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction.

Authors:  K Oishi; R L Raynor; P A Charp; J F Kuo
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

Review 2.  Signaling through phosphatidylcholine breakdown.

Authors:  J H Exton
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

3.  Enhancement of long-term potentiation by cis-unsaturated fatty acid: relation to protein kinase C and phospholipase A2.

Authors:  D J Linden; F S Sheu; K Murakami; A Routtenberg
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

4.  Protein kinase C during differentiation of human promyelocytic leukemia cell line, HL-60.

Authors:  K Hashimoto; A Kishimoto; H Aihara; I Yasuda; K Mikawa; Y Nishizuka
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

Review 5.  Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers.

Authors:  J Axelrod; R M Burch; C L Jelsema
Journal:  Trends Neurosci       Date:  1988-03       Impact factor: 13.837

6.  Disparate effects of activators of protein kinase C on HL-60 promyelocytic leukemia cell differentiation.

Authors:  M J Morin; D Kreutter; H Rasmussen; A C Sartorelli
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

Review 7.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression.

Authors:  S J Collins
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

8.  Dissociation of protein kinase C activation from phorbol ester-induced maturation of HL-60 leukemia cells.

Authors:  D Kreutter; A B Caldwell; M J Morin
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

9.  Differentiation of HL-60 promyelocytic leukemia cells: simultaneous determination of phagocytic activity and cell cycle distribution by flow cytometry.

Authors:  O C Blair; R Carbone; A C Sartorelli
Journal:  Cytometry       Date:  1986-03

10.  Failure of 1-oleoyl-2-acetylglycerol to mimic the cell-differentiating action of 12-O-tetradecanoylphorbol 13-acetate in HL-60 cells.

Authors:  S Yamamoto; H Gotoh; E Aizu; R Kato
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

View more
  9 in total

1.  Carcinogenic potential of duodenal reflux juice from patients with long-standing postgastrectomy.

Authors:  Z F Ma; Z Y Wang; J R Zhang; P Gong; H L Chen
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Regulation of phospholipase A2 in human leukemia cell lines: its implication for intracellular signaling.

Authors:  Y Tsujishita; Y Asaoka; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  Abnormal serum lysophospholipids in multiple myeloma patients.

Authors:  T Sasagawa; M Okita; J Murakami; T Kato; A Watanabe
Journal:  Lipids       Date:  1999-01       Impact factor: 1.880

4.  Activation of protein kinase C by lysophosphatidic acid: dependence on composition of phospholipid vesicles.

Authors:  J J Sando; O I Chertihin
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

5.  The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes.

Authors:  N Fuller; R P Rand
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

6.  Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.

Authors:  Ming-Zhu Yin; Shu Tan; Xia Li; Yan Hou; Guosheng Cao; Kang Li; Junping Kou; Ge Lou
Journal:  Tumour Biol       Date:  2015-11-13

7.  Detergent properties influence the stability of the glycophorin A transmembrane helix dimer in lysophosphatidylcholine micelles.

Authors:  Michael Stangl; Anbazhagan Veerappan; Anja Kroeger; Peter Vogel; Dirk Schneider
Journal:  Biophys J       Date:  2012-12-18       Impact factor: 4.033

8.  Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition.

Authors:  Shuyan Chen; Lihua Yao; Timothy J Cunningham
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

9.  Exposure to p,p'-DDE Induces Morphological Changes and Activation of the PKCα-p38-C/EBPβ Pathway in Human Promyelocytic HL-60 Cells.

Authors:  Nallely A Torres-Avilés; Damaris Albores-García; Ana L Luna; Monica Moreno-Galván; Mariana Salgado-Bustamante; Diana Patricia Portales-Pérez; Emma S Calderón-Aranda
Journal:  Biomed Res Int       Date:  2016-10-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.